Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)

44.97 USD  |  NASDAQ  |  Jul 31, 16:00
More

Cerevel Therapeutics Holdings EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for CERE:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade